Icahn School of Medicine at Mount Sinai

Health Technology

Honeywell | May 27, 2022

Honeywell announced the signing of a non-binding memorandum of understanding (MoU) with Narayana Hrudayalaya Limited to identify, assess and collaborate on opportunities for the latter's digital transformation journey. This will enable Narayana Health to offer technology-driven, affordable and accessible healthcare for all. The MoU is subject to definitive agreements to be executed between Honeywell and Narayana Health. "These are times of great promise and even greater opp...

Future of Healthcare

SpineGuard | June 08, 2022

pineGuard an innovative company that deploys its DSG sensing technology to secure and streamline the placement of bone implants, announces the launch of a new three-year collaboration program with two labs of Sorbonne University CNRS and Inserm: the ISIR. DSG is based on the local measurement of electrical conductivity of tissues in real time without X-ray imaging, with a sensor located at the tip of the drilling instrument. Its efficacy was proven by more than 90,000 surgeries acro...

Medical Devices

Businesswire | June 16, 2023

Caresyntax, the leading vendor-neutral enterprise surgical data and intelligence platform designed to make surgery smarter and safer, announced a strategic collaboration with ProAssurance Corporation one of the nation's leading medical professional liability insurers, to provide innovative Caresyntax surgical intelligence tools to ProAssurance’s insured surgeons. Using Caresyntax’s transformational surgical intelligence platform, ProAssurance insured surgeons can...

HealthIT Analytics | April 10, 2020

As the COVID-19 pandemic continues to disrupt the status quo, the healthcare industry is turning to real-world data to better understand, monitor, and prepare for whatever the virus may bring. From patient surveys and EHR information, to studies on past outbreaks and hospital capacity, leaders are harnessing the power of real-world data to observe patterns and make critical decisions. Defined by the FDA as information derived from sources other than traditional clinical trials, real-world ...